An Early Assessment of the ESKD Treatment Choices Model on Kidney Transplant Waitlisting.
作者信息
Drewry Kelsey
机构信息
Department of Surgery, Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN.
出版信息
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):9-11. doi: 10.2215/CJN.0000000629. Epub 2024 Dec 12.
Abstract
摘要
相似文献
1
An Early Assessment of the ESKD Treatment Choices Model on Kidney Transplant Waitlisting.对肾移植等待名单上的终末期肾病治疗选择模型的早期评估。
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):9-11. doi: 10.2215/CJN.0000000629. Epub 2024 Dec 12.
2
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.成人肾病综合征中原发性膜性肾病的免疫抑制治疗。
Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4.
4
Variation in Kidney Transplant Referral, Living Donor Contacts, Waitlisting, and Kidney Transplant Across Regional Renal Programs in Ontario, Canada: A Population-Based Cohort Study.加拿大安大略省各区域肾脏项目中肾移植转诊、活体供体联系、等待名单登记及肾移植情况的差异：一项基于人群的队列研究
Can J Kidney Health Dis. 2025 Jun 26;12:20543581251346048. doi: 10.1177/20543581251346048. eCollection 2025.
5
Effect of pre-end-stage kidney disease nephrology care on the association between neighborhood poverty and referral for kidney transplantation among patients with end-stage kidney disease.终末期肾病前期肾病护理对社区贫困与终末期肾病患者肾移植转诊之间关联的影响。
J Clin Epidemiol. 2025 Jun 24;185:111878. doi: 10.1016/j.jclinepi.2025.111878.
6
Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data.电子健康记录数据中识别终末期肾病算法的验证
Am J Kidney Dis. 2025 Aug;86(2):212-221.e1. doi: 10.1053/j.ajkd.2025.03.021. Epub 2025 May 15.
7
Glucose targets for preventing diabetic kidney disease and its progression.预防糖尿病肾病及其进展的血糖目标。
Cochrane Database Syst Rev. 2017 Jun 8;6(6):CD010137. doi: 10.1002/14651858.CD010137.pub2.
8
Subsequent kidney transplant after pediatric heart transplant: Prevalence and risk factors.儿童心脏移植后再次行肾脏移植：发生率和危险因素。
Am J Transplant. 2024 Jul;24(7):1267-1278. doi: 10.1016/j.ajt.2024.02.027. Epub 2024 Feb 29.
9
Dietary interventions for adults with chronic kidney disease.针对成年慢性肾病患者的饮食干预措施。
Cochrane Database Syst Rev. 2017 Apr 23;4(4):CD011998. doi: 10.1002/14651858.CD011998.pub2.
10
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
本文引用的文献
1
Early Effects of the ESRD Treatment Choices Model on Kidney Transplant Waitlist Additions.终末期肾病治疗选择模型对肾脏移植等待名单增加的早期影响。
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):124-135. doi: 10.2215/CJN.0000000000000571. Epub 2024 Oct 16.
2
Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant.家庭透析使用和肾移植的按效付费激励措施。
JAMA Health Forum. 2024 Jun 30;5(6.9):e242055. doi: 10.1001/jamahealthforum.2024.2055.
3
OPTN/SRTR 2021 Annual Data Report: COVID-19.美国移植学会/肾脏数据系统 2021 年年度数据报告：COVID-19。
Am J Transplant. 2023 Feb;23(2 Suppl 1):S475-S522. doi: 10.1016/j.ajt.2023.02.011.
4
Medicare Advantage Enrollment Among Beneficiaries With End-Stage Renal Disease in the First Year of the 21st Century Cures Act.21 世纪治愈法案实施第一年末期肾病受益人的医疗保险优势登记。
JAMA. 2023 Mar 14;329(10):810-818. doi: 10.1001/jama.2023.1426.
5
Association of the End-Stage Renal Disease Treatment Choices Payment Model With Home Dialysis Use at Kidney Failure Onset From 2016 to 2022.2016 年至 2022 年期间，终末期肾脏疾病治疗选择支付模式与肾衰竭起始时家庭透析使用的关联。
JAMA Netw Open. 2023 Feb 1;6(2):e230806. doi: 10.1001/jamanetworkopen.2023.0806.
6
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical Trial.为治疗终末期肾病患者并使用居家透析的医疗机构和临床医生提供经济激励：一项随机临床试验。
JAMA Health Forum. 2022 Oct 7;3(10):e223503. doi: 10.1001/jamahealthforum.2022.3503.
7
Treatment Patterns and Characteristics of Dialysis Facilities Randomly Assigned to the Medicare End-Stage Renal Disease Treatment Choices Model.随机分配到医疗保险终末期肾脏疾病治疗选择模型的透析机构的治疗模式和特征。
JAMA Netw Open. 2022 Aug 1;5(8):e2225516. doi: 10.1001/jamanetworkopen.2022.25516.
Zotero 插件